CD4 and metabolic syndrome: Another study by Echeverria et al. [53] reported that polymorphisms in genes associated with the development of atherogenic dyslipidemia, especially variants in the APOA5 gene, can influence the circulating CD4 T-cell levels in chronically HIV-infected patients.